Elevance Health Executive Purchases $1.1 Billion in Company Stock Amid Major Adversities

Insider Steven H. Collis of Elevance Health, Inc. (NASDAQ: ELV) purchased 3,000 shares of the company’s common stock in open-market transactions on March 5 at an average price of $289.84 per share, investing approximately $869,520 (about ₩1.1 billion), according to a recent filing. Following this transaction, the value of Collis’s directly held shares rose to about $1.05 million (roughly ₩1.4 billion), further increasing his personal economic exposure to the company’s stock.

Recently, Elevance Health reported its Q4 2025 and full-year results and provided an outlook for 2026. However, conservative guidance led to a double-digit decline in the share price over a short period, amplifying volatility. Regulatory risk has also come into focus, as the U.S. Centers for Medicare & Medicaid Services has signaled potential sanctions related to Medicare Advantage, further dampening investor sentiment. ()

Elevance Health is a leading healthcare benefits company that provides health insurance and related services nationwide under the Blue Cross and Blue Shield brands. Formerly known as Anthem and headquartered in Indianapolis, it operates a diversified portfolio—including insurance, medical services, and digital health platforms—serving tens of millions of members. ()